News
Successfully concluded the routine inspection of our toothpaste products on the market by Jiangning District Market Supervision Administration

Successfully concluded the routine inspection of our toothpaste products on the market by Jiangning District Market Supervision Administration

On August 21, 2024 at 3:30 pm, the Jiangning District Market Supervision Administration came to our company for a routine inspection of the market launch of toothpaste products.

22

2024

/

08

The Jiangsu Provincial Economic Branch of the Peasants and Workers Party and the Zhangjiagang Municipal Committee jointly launched party history education and enterprise inspection activities.

The Jiangsu Provincial Economic Branch of the Peasants and Workers Party and the Zhangjiagang Municipal Committee jointly launched party history education and enterprise inspection activities.

23

2023

/

10

Hufu Hunong skin bacteriostatic agent, inhibit fungi, improve skin itching and inflammation

Hufu Hunong skin bacteriostatic agent, inhibit fungi, improve skin itching and inflammation

14

2023

/

09

Nanjing daozhuang network technology co., ltd. Xu zong and his party visited

Nanjing daozhuang network technology co., ltd. Xu zong and his party visited

07

2023

/

09

The theme education and study of

The theme education and study of "condensing the heart, casting the soul, strengthening the foundation, uniting and striving for a new journey" and the research activity of "promoting the inheritance and innovation of traditional Chinese medicine" of the Jiangsu provincial branch of the rural labor party were successfully held in the company.

03

2023

/

08

Cooperation with Yangzijiang Pharmaceutical

Cooperation with Yangzijiang Pharmaceutical

Nanjing Baidier Biopharmaceutical Co., Ltd. will transfer the development technology of nanalidomide raw materials and capsules to our company in the future. The technology is mature, stable and reliable in quality. After our company has transferred the raw material development technology and capsule development technology of this product, we have completed further industrial scale-up production on this basis, successfully completed multiple batches of verification production, successfully passed the bioequivalence study, and obtained the production number in July 2020. This technology transformation has realized the key process from development to production, and has played a very important role in the quality and listing of our products. On September 18, the company sold the first box of lenalidomide capsules (Youjia) produced by Yangzijiang Pharmaceutical Group Co., Ltd., from landing to successful listing.

19

2023

/

04

Nanjing Baidier Biopharmaceutical Co., Ltd.

About Us    Products    R & D Services    Company Platform    Business Cooperation    Merchants join    News    Join us

Telephone:025-82232217

Telephone:17372239522

Address: Building 3, Tianan Digital City, 36 Yongfeng Avenue, Qinhuai District, Nanjing

 

图片名称

WeChat

图片名称

Jingdong

图片名称

Taobao

©2023 Nanjing Biodealpharm Co.,Ltd

Technical Support:China Enterprise Power Nanjing

SEO

Business License